Enriched cancer pathway | Genes under regulation | P value |
GnRH signaling pathway |
7 genes: MAP3K2, EGFR, KRAS, NRAS, PLD1, MAPK1, MAPK8
|
0.0004319 |
Gap junction |
6 genes: MAP3K2, EGFR, GNAI3, KRAS, NRAS, MAPK1
|
0.001357 |
Tight junction |
7 genes: GNAI3, KRAS, NRAS, MPP5, YES1, CASK, VAPA
|
0.002174 |
Dorso.ventral axis formation |
3 genes: EGFR, KRAS, MAPK1
|
0.004446 |
ErbB signaling pathway |
5 genes: EGFR, KRAS, NRAS, MAPK1, MAPK8
|
0.006397 |
Protein processing in endoplasmic reticulum |
7 genes: HSPA5, ATXN3, MAPK8, EIF2AK2, RAD23B, SSR1, EDEM3
|
0.007785 |
Insulin signaling pathway |
6 genes: SOCS4, KRAS, NRAS, PPP1CB, MAPK1, MAPK8
|
0.01101 |
Melanogenesis |
5 genes: GNAI3, KRAS, NRAS, MAPK1, FZD3
|
0.0118 |
Long.term potentiation |
4 genes: KRAS, NRAS, PPP1CB, MAPK1
|
0.01467 |
Long.term depression |
4 genes: GNAI3, KRAS, NRAS, MAPK1
|
0.01467 |
Adherens junction |
4 genes: SSX2IP, EGFR, MAPK1, YES1
|
0.01688 |
Hippo signaling pathway |
6 genes: MPP5, FRMD6, PPP1CB, ID1, FZD3, YWHAZ
|
0.01805 |
Pantothenate and CoA biosynthesis |
2 genes: PANK3, PPCS
|
0.0191 |
Endocytosis |
7 genes: STAMBP, ARAP2, EGFR, PLD1, RAB22A, ITCH, ASAP2
|
0.02026 |
Fc epsilon RI signaling pathway |
4 genes: KRAS, NRAS, MAPK1, MAPK8
|
0.0219 |
Neurotrophin signaling pathway |
5 genes: KRAS, NRAS, MAPK1, MAPK8, YWHAZ
|
0.02868 |
MAPK signaling pathway |
8 genes: MAP3K2, EGFR, ELK4, KRAS, NRAS, MAPK1, MAPK8, CASP3
|
0.02905 |
Cell cycle |
5 genes: DBF4, HDAC2, RBL1, YWHAZ, SMC1A
|
0.02953 |
Progesterone.mediated oocyte maturation |
4 genes: GNAI3, KRAS, MAPK1, MAPK8
|
0.02989 |
Axon guidance |
5 genes: ARHGEF12, GNAI3, KRAS, NRAS, MAPK1
|
0.03128 |
NOD.like receptor signaling pathway |
3 genes: XIAP, MAPK1, MAPK8
|
0.04508 |